LINC-ADAIN
gene geneOn this page
Also known as linc-DMRT2lnc-DRMT2TCONS_00015639
Summary
LINC-ADAIN (long intergenic non-coding adipose anti-inflammatory, HGNC:49686) is a long non-coding RNA gene on chromosome 9p24.3.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:49686 |
| Approved symbol | LINC-ADAIN |
| Name | long intergenic non-coding adipose anti-inflammatory |
| Location | 9p24.3 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | linc-DMRT2, lnc-DRMT2, TCONS_00015639 |
| Ensembl gene | ENSG00000281769 |
| Ensembl biotype | lncRNA |
| Entrez | 102800446 |
| RNAcentral | URS000075B229 — lncRNA, 499 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 lncRNA
ENST00000625222, ENST00000778964, ENST00000778965
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000625222 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003765753 | 1045625 | 1048641 |
Expression profiles
Bgee: expression breadth broad, 68 present calls, max score 75.76.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1156 / max 54.1667, expressed in 18 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 95818 | 0.1156 | 18 |
Top tissues by expression
74 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cortex of kidney | UBERON:0001225 | 75.76 | gold quality |
| metanephros cortex | UBERON:0010533 | 72.73 | gold quality |
| kidney | UBERON:0002113 | 71.84 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 70.70 | gold quality |
| subcutaneous adipose tissue | UBERON:0002190 | 69.88 | gold quality |
| thymus | UBERON:0002370 | 67.11 | silver quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.61 | gold quality |
| quadriceps femoris | UBERON:0001377 | 65.49 | gold quality |
| cerebellar vermis | UBERON:0004720 | 64.61 | gold quality |
| adipose tissue | UBERON:0001013 | 64.20 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 63.76 | gold quality |
| thoracic mammary gland | UBERON:0005200 | 63.66 | gold quality |
| bone marrow | UBERON:0002371 | 61.71 | silver quality |
| spleen | UBERON:0002106 | 59.38 | silver quality |
| liver | UBERON:0002107 | 57.00 | gold quality |
| omental fat pad | UBERON:0010414 | 56.56 | gold quality |
| apex of heart | UBERON:0002098 | 54.24 | gold quality |
| calcaneal tendon | UBERON:0003701 | 54.02 | silver quality |
| skeletal muscle tissue | UBERON:0001134 | 53.83 | silver quality |
| multicellular organism | UBERON:0000468 | 53.00 | gold quality |
| prefrontal cortex | UBERON:0000451 | 52.70 | silver quality |
| urinary bladder | UBERON:0001255 | 50.72 | gold quality |
| lymph node | UBERON:0000029 | 50.40 | silver quality |
| muscle of leg | UBERON:0001383 | 49.45 | gold quality |
| frontal cortex | UBERON:0001870 | 49.05 | silver quality |
| tibial nerve | UBERON:0001323 | 48.69 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 48.46 | gold quality |
| gastrocnemius | UBERON:0001388 | 48.39 | gold quality |
| placenta | UBERON:0001987 | 48.23 | gold quality |
| left uterine tube | UBERON:0001303 | 48.00 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 2.10 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 2)
- These results conclude linc01230 as a novel modifier in PPARgamma-mediated activation of Akt in endothelial function. (PMID:30454889)
- linc-ADAIN, a human adipose lincRNA, regulates adipogenesis by modulating KLF5 and IL-8 mRNA stability. (PMID:38753486)
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.